Acknowledgements
The authors thank all survey participants from Phnom Penh and Siem Reap, Cambodia; Bandung, Jakarta, Medan, Manado, Surabaya, and Yogjakarta, Indonesia; Ipoh, Kota Kinabalu, Kuala Lumpur, Kuching, and Penang, Malaysia; Mandalay, Yangon, and Yankin, Myanmar; Batangas, Davao City and Manila, Philippines; Bangkok, Chiang Mai, and Songkla, Thailand; and Hanoi, Ho Chi Minh City, and Hue, Vietnam.
References
1. Tan AM, Ha C, Li CF, et al. Viva-Asia Blood and Marrow Transplantation Groups - A Survey of Consortium Activity over a 12-year Period (2000 to 2011). Ann Acad Med Singapore.2016;45(3):106-109.
2. Ali K, Sutaryo S, Purwanto I, et al. Yogyakarta Pediatric Cancer Registry: an international collaborative project of University Gadjah Mada, University of Saskatchewan, and the Saskatchewan Cancer Agency.Asian Pac J Cancer Prev. 2010;11(1):131-136.
3. Park KD, Hong CR, Choi JY, et al. Foundation of pediatric cancer treatment in Lao People’s Democratic Republic at the Lao-Korea National Children’s Hospital. Pediatr Hematol Oncol. 2018;35(4):268-275.
4. Halbert J, Khaing AA. Overview of pediatric oncology and hematology in Myanmar. South Asian J Cancer. 2014;3(1):78-82.
5. Bidwell SS, Peterson CC, Demanelis K, et al. Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011. Pediatr Blood Cancer.2019;66(1):e27428.
6. Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis.Lancet Oncol. 2019;20(4):483-493.
7. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/age-specific_table_sel.aspx.
8. International Incidence of Childhood Cancer, Volume III (electronic version). International Agency for Research on Cancer; 2017. http://iicc.iarc.fr/results/. Accessed 14 Mar 2020.
9. Rajagopal R, Abd-Ghafar S, Ganesan D, et al. Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia. J Glob Oncol. 2017;3(2):143-156.
10. Sangkhathat S, Chotsampancharaen T, Kayasut K, et al. Outcomes of pediatric nephroblastoma in southern Thailand. Asian Pac J Cancer Prev. 2008;9(4):643-647.
11. Fabian ID, Abdallah E, Abdullahi SU, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol.2020.
12. Adham M, Stoker SD, Wildeman MA, et al. Current status of cancer care for young patients with nasopharyngeal carcinoma in Jakarta, Indonesia. PLoS One. 2014;9(7):e102353.
13. Wongmas P, Jetsrisuparb A, Komvilaisak P, et al. Incidences, Trends and Long Term Outcomes of Retinoblastoma in Three Cancer Registries, Thailand. Asian Pac J Cancer Prev. 2015;16(16):6899-6902.
14. Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols.Asian Pac J Cancer Prev. 2015;16(11):4609-4614.
15. Wongmeerit P, Suwanrungruang K, Jetsrisuparb A, Komvilaisak P, Wiangnon S. Trends in Survival of Childhood Cancers in a University Hospital, Northeast Thailand, 19932012. Asian Pac J Cancer Prev.2016;17(7):3515-3519.
16. Tah PC, Nik Shanita S, Poh BK. Nutritional status among pediatric cancer patients: a comparison between hematological malignancies and solid tumors. J Spec Pediatr Nurs. 2012;17(4):301-311.
17. Howard SC, Davidson A, Luna-Fineman S, et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP).Pediatr Blood Cancer. 2017;64 Suppl 5.
18. Madani A, Zafad S, Harif M, et al. Treatment of Wilms tumor according to SIOP 9 protocol in Casablanca, Morocco. Pediatr Blood Cancer. 2006;46(4):472-475.
19. Pedrosa F, Bonilla M, Liu A, et al. Effect of malnutrition at the time of diagnosis on the survival of children treated for cancer in El Salvador and Northern Brazil. J Pediatr Hematol Oncol.2000;22(6):502-505.
20. Kreyer J, Ranft A, Timmermann B, et al. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy. Pediatr Blood Cancer.2018;65(12):e27384.
21. George PE, Fahdil G, Luutu I, et al. Analysis of management decisions and outcomes of a weekly multidisciplinary pediatric tumor board meeting in Uganda. Future Sci OA. 2019;5(9):FSO417.
22. Thenappan A, Halaweish I, Mody RJ, et al. Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer. Pediatr Blood Cancer.2017;64(2):254-258.
23. Rosell L, Alexandersson N, Hagberg O, Nilbert M. Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Serv Res. 2018;18(1):249.
24. Shulman T, Bain CA, Raikundalia GK, Sharma RK. Obstacles to Sustaining Cancer Care Multidisciplinary Team Meetings: An Australian Survey. 2013.
25. Taylor CT, Ramirez AR. Multidisciplinary team members’ views about MDT working: Results from a survey commissioned by the National Cancer Action Team. In. London SE1 7EH: Cancer Research UK Promoting Early Presentation Group; 2009.
26. Norman G. Likert scales, levels of measurement and the ”laws” of statistics. Adv Health Sci Educ Theory Pract. 2010;15(5):625-632.
27. Sullivan GM, Artino AR. Analyzing and interpreting data from likert-type scales. J Grad Med Educ. 2013;5(4):541-542.
28. Nations U. World Population Prospects 2019: Data Booket. ST/ESA/SER.A/424. In: Department of Economic and Social Affairs, Population Division: https://population.un.org/wpp/Publications/Files/WPP2019_DataBooklet.pdf.
29. Rodriguez-Galindo C, Friedrich P, Alcasabas P, et al. Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge. J Clin Oncol.2015;33(27):3065-3073.
30. Rodriguez-Galindo C, Friedrich P, Morrissey L, Frazier L. Global challenges in pediatric oncology. Curr Opin Pediatr.2013;25(1):3-15.
31. Howard SC, Metzger ML, Wilimas JA, et al. Childhood cancer epidemiology in low-income countries. Cancer.2008;112(3):461-472.
32. Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer. 1988;42(4):511-520.
33. G upta S, Howard SC, Hunger SP, et al. Treating Childhood Cancer in Low- and Middle-Income Countries. In: Gelband H JP, Sankaranarayanan R, et al., ed. Cancer: Disease Control Priorities, Third Edition.Vol 3. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015.
34. Bickler SW, Rode H. Surgical services for children in developing countries. Bull World Health Organ. 2002;80(10):829-835.
35. Surgery GIfCs. Global Initiative for Children’s Surgery: A Model of Global Collaboration to Advance the Surgical Care of Children.World J Surg. 2019;43(6):1416-1425.
36. Goodman LF, St-Louis E, Yousef Y, et al. The Global Initiative for Children’s Surgery: Optimal Resources for Improving Care. Eur J Pediatr Surg. 2018;28(1):51-59.
37. Moore MA, Shin HR, Curado MP, Sobue T. Establishment of an Asian Cancer Registry Network - problems and perspectives. Asian Pac J Cancer Prev. 2008;9(4):815-832.
38. Hamidah A, Rustam ZA, Tamil AM, Zarina LA, Zulkifli ZS, Jamal R. Prevalence and parental perceptions of complementary and alternative medicine use by children with cancer in a multi-ethnic Southeast Asian population. Pediatr Blood Cancer. 2009;52(1):70-74.
39. Mostert S, Gunawan S, van Dongen JA, et al. Health-care providers’ perspectives on childhood cancer treatment in Manado, Indonesia.Psychooncology. 2013;22(11):2522-2528.
40. Standards for Pediatric Cancer Centers. Pediatrics.2014;134(2):410-414.
41. Borras JM, Albreht T, Audisio R, et al. Policy statement on multidisciplinary cancer care. Eur J Cancer. 2014;50(3):475-480.